Antigenics
New reports from Antigenics detailed
Published in Lab Business Week, May 6th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Antigenics.
Report 1: Antigenics Inc. (NASDAQ: AGEN) today announced the appointment of Brian Corvese to its board of directors. Mr. Corvese is currently president and founder of Vencor Capital. He was formerly a partner at Soros Fund Management as well as a partner at Chancellor Capital Management.
"With more than 25 years of financial and investment experience, Brian brings a valuable portfolio of assets to Antigenics as a board member. We look forward to his guidance, having had an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-05-06)
More Articles from Lab Business Week
- Biochemistry
Studies from Haskins Laboratories yield new data on biochemistry - Cell Biology
Research from Abbott Laboratories in the area of cell biology published - Chemotherapy
Reports from Haskins Laboratories highlight recent research in chemotherapy - Drug Development
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets - Flu Vaccines
Carrington Subsidiary DelSite Biotechnologies Secures Antigen for Phase I Clinical Trial of Nasal Powder Influenza Vaccine - Hepatitis C Virus Therapy
Researchers from Abbott Laboratories report on findings in hepatitis C virus therapy - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
